Overview

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

Status:
Not yet recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Inventage Lab., Inc.
Treatments:
Donepezil